The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Treatment Market Research Report 2025
Synopsis
Global Intravenous Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospitals and Clinics
Outpatient clinic
Home Care
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Intravenous Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospitals and Clinics
Outpatient clinic
Home Care
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Intravenous Treatment Market Overview
1.1 Product Overview and Scope of Intravenous Treatment
1.2 Intravenous Treatment Segment by Type
1.2.1 Global Intravenous Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Treatment Segment by Application
1.3.1 Global Intravenous Treatment Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Outpatient clinic
1.3.4 Home Care
1.4 Global Intravenous Treatment Market Size Estimates and Forecasts
1.4.1 Global Intravenous Treatment Revenue 2018-2029
1.4.2 Global Intravenous Treatment Sales 2018-2029
1.4.3 Global Intravenous Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intravenous Treatment Market Competition by Manufacturers
2.1 Global Intravenous Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intravenous Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intravenous Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Intravenous Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intravenous Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Treatment, Product Type & Application
2.7 Intravenous Treatment Market Competitive Situation and Trends
2.7.1 Intravenous Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Treatment Players Market Share by Revenue
2.7.3 Global Intravenous Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Treatment Retrospective Market Scenario by Region
3.1 Global Intravenous Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intravenous Treatment Global Intravenous Treatment Sales by Region: 2018-2029
3.2.1 Global Intravenous Treatment Sales by Region: 2018-2023
3.2.2 Global Intravenous Treatment Sales by Region: 2024-2029
3.3 Global Intravenous Treatment Global Intravenous Treatment Revenue by Region: 2018-2029
3.3.1 Global Intravenous Treatment Revenue by Region: 2018-2023
3.3.2 Global Intravenous Treatment Revenue by Region: 2024-2029
3.4 North America Intravenous Treatment Market Facts & Figures by Country
3.4.1 North America Intravenous Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intravenous Treatment Sales by Country (2018-2029)
3.4.3 North America Intravenous Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Treatment Market Facts & Figures by Country
3.5.1 Europe Intravenous Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intravenous Treatment Sales by Country (2018-2029)
3.5.3 Europe Intravenous Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intravenous Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Intravenous Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Treatment Market Facts & Figures by Country
3.7.1 Latin America Intravenous Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intravenous Treatment Sales by Country (2018-2029)
3.7.3 Latin America Intravenous Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intravenous Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intravenous Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Treatment Sales by Type (2018-2029)
4.1.1 Global Intravenous Treatment Sales by Type (2018-2023)
4.1.2 Global Intravenous Treatment Sales by Type (2024-2029)
4.1.3 Global Intravenous Treatment Sales Market Share by Type (2018-2029)
4.2 Global Intravenous Treatment Revenue by Type (2018-2029)
4.2.1 Global Intravenous Treatment Revenue by Type (2018-2023)
4.2.2 Global Intravenous Treatment Revenue by Type (2024-2029)
4.2.3 Global Intravenous Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Intravenous Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intravenous Treatment Sales by Application (2018-2029)
5.1.1 Global Intravenous Treatment Sales by Application (2018-2023)
5.1.2 Global Intravenous Treatment Sales by Application (2024-2029)
5.1.3 Global Intravenous Treatment Sales Market Share by Application (2018-2029)
5.2 Global Intravenous Treatment Revenue by Application (2018-2029)
5.2.1 Global Intravenous Treatment Revenue by Application (2018-2023)
5.2.2 Global Intravenous Treatment Revenue by Application (2024-2029)
5.2.3 Global Intravenous Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Intravenous Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ICU Medical Inc. (U.S.)
6.1.1 ICU Medical Inc. (U.S.) Corporation Information
6.1.2 ICU Medical Inc. (U.S.) Description and Business Overview
6.1.3 ICU Medical Inc. (U.S.) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ICU Medical Inc. (U.S.) Intravenous Treatment Product Portfolio
6.1.5 ICU Medical Inc. (U.S.) Recent Developments/Updates
6.2 B. Braun Melsungen AG (Germany)
6.2.1 B. Braun Melsungen AG (Germany) Corporation Information
6.2.2 B. Braun Melsungen AG (Germany) Description and Business Overview
6.2.3 B. Braun Melsungen AG (Germany) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 B. Braun Melsungen AG (Germany) Intravenous Treatment Product Portfolio
6.2.5 B. Braun Melsungen AG (Germany) Recent Developments/Updates
6.3 Fresenius Kabi AG (Germany)
6.3.1 Fresenius Kabi AG (Germany) Corporation Information
6.3.2 Fresenius Kabi AG (Germany) Description and Business Overview
6.3.3 Fresenius Kabi AG (Germany) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi AG (Germany) Intravenous Treatment Product Portfolio
6.3.5 Fresenius Kabi AG (Germany) Recent Developments/Updates
6.4 Baxter (U.S.)
6.4.1 Baxter (U.S.) Corporation Information
6.4.2 Baxter (U.S.) Description and Business Overview
6.4.3 Baxter (U.S.) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter (U.S.) Intravenous Treatment Product Portfolio
6.4.5 Baxter (U.S.) Recent Developments/Updates
6.5 Amanta Healthcare (India)
6.5.1 Amanta Healthcare (India) Corporation Information
6.5.2 Amanta Healthcare (India) Description and Business Overview
6.5.3 Amanta Healthcare (India) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Amanta Healthcare (India) Intravenous Treatment Product Portfolio
6.5.5 Amanta Healthcare (India) Recent Developments/Updates
6.6 Terumo Medical Corporation (Tokyo)
6.6.1 Terumo Medical Corporation (Tokyo) Corporation Information
6.6.2 Terumo Medical Corporation (Tokyo) Description and Business Overview
6.6.3 Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Portfolio
6.6.5 Terumo Medical Corporation (Tokyo) Recent Developments/Updates
6.7 Grifols S.A. (Spain)
6.6.1 Grifols S.A. (Spain) Corporation Information
6.6.2 Grifols S.A. (Spain) Description and Business Overview
6.6.3 Grifols S.A. (Spain) Intravenous Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grifols S.A. (Spain) Intravenous Treatment Product Portfolio
6.7.5 Grifols S.A. (Spain) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Treatment Industry Chain Analysis
7.2 Intravenous Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Treatment Production Mode & Process
7.4 Intravenous Treatment Sales and Marketing
7.4.1 Intravenous Treatment Sales Channels
7.4.2 Intravenous Treatment Distributors
7.5 Intravenous Treatment Customers
8 Intravenous Treatment Market Dynamics
8.1 Intravenous Treatment Industry Trends
8.2 Intravenous Treatment Market Drivers
8.3 Intravenous Treatment Market Challenges
8.4 Intravenous Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
